Relapsed Diffuse Large B-cell Lymphoma (DLBCL)

Also known as: Relapse Diffuse Large B Cell Lymphoma / Relapsed Diffuse Large B Cell Lymphoma / Relapsed Diffuse Large B-Cell Lymphoma / Relapsed, Diffuse Large B-cell Lymphoma / Relapsed Large B-cell Lymphoma / Diffuse Large B Cell Lymphoma Relapsed / Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL)

DrugDrug NameDrug Description
DB13915Axicabtagene ciloleucelA CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma.
DB16582Lisocabtagene maraleucelA CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas.
DB16222Loncastuximab tesirineAn antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas.
DB13881TisagenlecleucelA CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma.
DrugDrug NamePhaseStatusCount
DB11891Fimepinostat1Completed1
DB09053Ibrutinib1Active Not Recruiting1
DB06186Ipilimumab1Completed1
DB13982Lutetium Lu-1771Completed1
DB09035Nivolumab1Completed1
DB14867Parsaclisib1Completed1
DB00073Rituximab1Active Not Recruiting1
DB00073Rituximab1Completed1
DB12227Tetulomab tetraxetan Lu-1771Completed1
DB11581Venetoclax1Active Not Recruiting1
DB11581Venetoclax1Completed1
DB17364AUTO31 / 2Active Not Recruiting1
DB13915Axicabtagene ciloleucel1 / 2Active Not Recruiting1
DB12483Copanlisib1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB09053Ibrutinib1 / 2Completed2
DB00480Lenalidomide1 / 2Completed2
DB00073Rituximab1 / 2Completed1
DB00073Rituximab1 / 2Recruiting1
DB14922Tislelizumab1 / 2Recruiting1
DB11581Venetoclax1 / 2Active Not Recruiting1
DB11595Atezolizumab2Terminated1
DB00262Carmustine2Active Not Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB00987Cytarabine2Active Not Recruiting1
DB00773Etoposide2Active Not Recruiting1
DB00441Gemcitabine2Terminated2
DB16222Loncastuximab tesirine2Recruiting1
DB17339Maveropepimut-S2Recruiting1
DB01042Melphalan2Active Not Recruiting1
DB00526Oxaliplatin2Terminated2
DB09037Pembrolizumab2Recruiting1
DB06809Plerixafor2Active Not Recruiting1
DB00073Rituximab2Terminated1
DB15765Sintilimab2Not Yet Recruiting1
DB00958Carboplatin3Recruiting1
DB00773Etoposide3Recruiting1
DB00441Gemcitabine3Recruiting1
DB01181Ifosfamide3Recruiting1
DB16222Loncastuximab tesirine3Recruiting1
DB00526Oxaliplatin3Recruiting1
DB12240Polatuzumab vedotin3Recruiting1
DB00073Rituximab3Recruiting2